David M. Knott’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

David M. Knott’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.19M	Sell	20,000 -12,000	-38%	-$1.25M	0.8%	33
2021 Q2	$3M	Sell	32,000 -8,614	-21%	-$793K	1.06%	26
2021 Q1	$3.74M	Sell	40,614 -2,000	-5%	-$169K	1.6%	17
2020 Q4	$3.12M	Buy	42,614 +5,083	+14%	+$378K	1.41%	20
2020 Q3	$2.92M	Buy	37,531 +1,000	+3%	+$68.8K	1.71%	14
2020 Q2	$2.03M	Sell	36,531 -23,000	-39%	-$984K	1.11%	24
2020 Q1	$1.76M	Sell	59,531 -1,325	-2%	-$44.8K	1.11%	22
2019 Q4	$2.2M	Sell	60,856 -3,508	-5%	-$108K	0.89%	24
2019 Q3	$1.75M	Buy	64,364 +14,318	+29%	+$370K	0.74%	27
2019 Q2	$1.2M	Buy	50,046 +2,206	+5%	+$56K	0.51%	34
2019 Q1	$1.26M	Sell	47,840 -25,800	-35%	-$611K	0.5%	40
2018 Q4	$1.44M	Hold	73,640	–	–	0.68%	29
2018 Q3	$1.44M	Hold	73,640	–	–	0.47%	35
2018 Q2	$1.22M	Buy	+73,640	New	+$1.12M	0.46%	36
2018 Q1	–	Sell	-25,000	Closed	-$365K	–	120
2017 Q4	$365K	Buy	+25,000	New	+$351K	0.15%	69

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

David M. Knott's HZNP Position: Q3 2021 in Review

David M. Knott reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 38% in Q3 2021, selling an estimated $1.25M and leaving 20,000 shares worth $2.19M. The position accounts for 0.8% of the portfolio, ranked #33.

David M. Knott first reported a position in HZNP in Q4 2017 and has held it in 15 quarters since. The position peaked at $3.74M in Q1 2021. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

David M. Knott held 20,000 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $2.19M as of Q3 2021.
David M. Knott sold 12,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $1.25M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.8% of David M. Knott's portfolio in Q3 2021, its #33 holding.
David M. Knott first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2017 and has held it in 15 quarters since.
David M. Knott's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.74M in Q1 2021.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.